Further studies have confirmed that MYC is one of the genes significantly amplified in CRPC versus primary PCa [30], suggesting that repression of miR-34a expression may represent a fundamental component of the MYC tumorigenic program (Figure 3D). The gene discussed is MYC; the disease is posterior cortical atrophy.